Slim chance in the pharma dance
|
|
Overview
Your client, MedEx Innovations, is preparing to launch Slimvora, a GLP-1 weight loss drug expected to compete with Ozempic and Wegovy. After investing $8 billion in development, MedEx has hired your firm to design a launch strategy that maximizes return on investment and captures untapped market demand.
Formats available
đź“„ Peer practice PDF
Case info
Difficulty
Intermediate
Industry
Healthcare, pharmaceuticals and medical devices
Case type
Market entry
Geography
North America, USA
Additional info
Includes charts and/or data analysis
P.S. Are you preparing for consulting interviews?
Real interview drills. Sample answers from ex-McKinsey, BCG and Bain consultants. Plus technique overviews and premium 1-on-1 Expert coaching.
